Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing

Alternate BRAF splicing is the most common mechanism of acquired resistance to BRAF inhibitor treatment in melanoma. Recently, alternate BRAF exon 4–8 splicing was shown to involve an intronic mutation, located 51 nucleotides upstream of BRAF exon 9 within a predicted splicing branch point. This int...

Descripción completa

Detalles Bibliográficos
Autores principales: Pupo, Gulietta M., Boyd, Suzanah C., Fung, Carina, Carlino, Matteo S., Menzies, Alexander M., Pedersen, Bernadette, Johansson, Peter, Hayward, Nicholas K., Kefford, Richard F., Scolyer, Richard A., Long, Georgina V., Rizos, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426037/
https://www.ncbi.nlm.nih.gov/pubmed/28503307
http://dx.doi.org/10.1186/s40364-017-0098-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426037/
https://www.ncbi.nlm.nih.gov/pubmed/28503307
http://dx.doi.org/10.1186/s40364-017-0098-3

Ejemplares similares